Osteal Therapeutics Funding: $126M Raised, Series D (2024)
Osteal Therapeutics is based in San Clemente. It has raised $126M in total funding. Latest round: Series D.
Osteal Therapeutics funding overview
Osteal Therapeutics is based in San Clemente. Osteal Therapeutics has raised $126M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in May 2024. The round record for Osteal Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Zimmer Biomet, Johnson & Johnson Innovation – JJDC, Huimei Capital. 3 distinct backers are named across the disclosed rounds.
Osteal Therapeutics at a glance
Total raised
$126M
Latest round
Series D
Latest round date
May 2024
Headquarters
San Clemente
Notable investors
Zimmer Biomet, Johnson & Johnson Innovation – JJDC, Huimei Capital
Frequently asked about Osteal Therapeutics funding
How much has Osteal Therapeutics raised?
Osteal Therapeutics has raised $126M in total disclosed funding across the rounds on record.
Who has invested in Osteal Therapeutics?
Zimmer Biomet, Johnson & Johnson Innovation – JJDC, Huimei Capital are named among the investors backing Osteal Therapeutics.
What was the latest Osteal Therapeutics funding round?
The most recent disclosed round is a Series D, announced in May 2024.
Where is Osteal Therapeutics based?
Osteal Therapeutics is based in San Clemente.
When did Osteal Therapeutics last raise?
The last disclosed Osteal Therapeutics round closed in May 2024 at Series D.
Round data for Osteal Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Clemente and backer lists below.
